EANM’06 – CME Session VI
October 2, 2006, 11:30 – 13:00
Sentinel Node: Present and Future
Moderator: F. Pons (Barcelona)
Co-Moderator: O. Nieweg (Amsterdam)
- To know which are the current applications of the sentinel lymph node biopsy in oncology.
- To be aware of the challenges for sentinel node lymphoscintigraphy in the near future.
- To demonstrate the usefulness of lymphoscintigraphy for lymphatic mapping in malignant melanoma and breast cancer and to recognize lymphatic drainage patterns and sentinel node identification criteria in lymphoscintigraphy.
- To evaluate which patients with breast cancer or malignant melanoma are candidates for radio guided sentinel lymph node biopsy.
- To recognise the most controversial aspects of the sentinel node procedure in malignant melanoma patients.
- To appreciate the value of the sentinel node procedure as the standard of care in malignant melanoma patients, in accordance with the consensus of experts.
The course is designed for physicians with a background in nuclear medicine and oncology who are involved or interested in the field of sentinel lymph node biopsy. It will give a general overview of the present and future situation of the sentinel node procedure. Since the sentinel node concept has now been extended to many tumours types, the introductory lecture will centre on the latest applications and challenges for this technique. The second lecture will emphasise the importance of lymphoscintigraphy as the imaging standard for lymphatic mapping in malignant melanoma and breast cancer. These are the tumours where the sentinel node biopsy was first applied and therefore where most information is available. The third lecture will highlight the most relevant aspects of the recent controversy over the role of sentinel node procedure as the standard of care in malignant melanoma patients, in search of a consensus.
Sentinel lymph node; Lymphoscintigraphy; Malignant melanoma; Breast cancer